Lime Therapeutics
Prakrit Jena is the Co-Founder and CTO of Lime Therapeutics, a platform drug discovery company focused on therapies for cancer and neurodegenerative disorders. Prakrit has been in this role since January 2021. Prior to Lime Therapeutics, Prakrit was a Fellow at the Entrepreneurship Lab (ELabNYC) Bio & Health Tech from December 2017 to November 2022, and a Global Scholar at PreScouter, Inc. from May 2017 to November 2022. Prakrit also worked at Memorial Sloan Kettering Cancer Center, where they held various roles including Senior Research Scientist (July 2020 to July 2022), Research Associate (July 2017 to June 2020), and Research Scholar (June 2012 to June 2017). In addition, Prakrit was an External Consultant at Photon etc. for a brief period in July-August 2014.
Prakrit Jena completed their undergraduate education at Illinois Wesleyan University from 2001 to 2005. Prakrit earned a Bachelor of Science degree in Physics and Math during this time. Following their undergraduate studies, they pursued further education at the University of Illinois Urbana-Champaign, where they obtained a Doctor of Philosophy (Ph.D.) degree in Physics from 2005 to 2012.
This person is not in any teams
Lime Therapeutics
Lime Therapeutics aims to eliminate a variety of cancers by pursuing a novel approach targeting lipid metabolism. Cancers need lipids (often at high levels) in order to survive; thus finding drugs that can deprive cancers of lipids represents an attractive therapeutic strategy. However, technological barriers have prevented high-throughput drugdiscovery in this area.